Results 141 to 150 of about 84,355 (327)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis
Extranodal natural killer/T-cell lymphoma is a rare Epstein-Barr virus-associated aggressive lymphoma commonly involving the nasal and upper aerodigestive tract and, less commonly, extranodal sites such as skin and gastrointestinal tract.
Jayati Mallick+2 more
doaj
Childhood primary cutaneous non-T/non-B lymphoma followed by acute T-cell leukemia [PDF]
Thomas T. Tang+5 more
openalex +1 more source
Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis
Australasian Journal of Dermatology, EarlyView.
Mizuho Namba+6 more
wiley +1 more source
GPCR‐G protein signalling and its mutational landscape in cancer—Driver or passenger
G protein‐coupled receptors (GPCRs) play a crucial role in cellular signalling, regulating various physiological processes. Abnormal expression and mutations of GPCRs have been implicated in several types of cancer, influencing tumour initiation, progression and immune response.
Chenlin Feng+3 more
wiley +1 more source
Lichen Planus Follicularis Tumidus
Australasian Journal of Dermatology, EarlyView.
A. I. Oloruntoba+2 more
wiley +1 more source
Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T‐Cell Leukemia/Lymphoma
UMAP projection of CD4 T cells from ATLL patients specified a CD48‐deficient cluster, in which YY1 and EZH2 are upregulated. ABSTRACT The clinical and genetic presentation of adult T‐cell leukemia/lymphoma (ATLL) ranges from indolent to aggressive, making it difficult to identify common therapeutic targets.
Takuya Shimizu+5 more
wiley +1 more source
This study confirmed that hypomethylation‐induced upregulation of CD98 promoted ESCC cell proliferation by regulating the cell cycle and was correlated with poorer overall survival of ESCC patients. Combined panels of immunohistochemistry (CD98 and P53) are recommended for accurate diagnosis of esophageal precancerous lesions.
Xue Zhang+13 more
wiley +1 more source
Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases
HDACs play an important role in the occurrence and development of cardiovascular diseases, such as myocardial hypertrophy, hypertension, and atherosclerosis. HDAC inhibitors have broad prospects for the treatment of CVD, and different HDAC subtypes can act through different mechanisms.
Li‐Ying Zhang+4 more
wiley +1 more source
HTLV-I associated cutaneous T-cell lymphoma: report of a case with atypical clinical presentation [PDF]
Achiléa Lisbôa Bittencourt+5 more
openalex +1 more source